Dedicated to advancing brain health and transforming lives

Equally important to what we deliver is how we deliver it. Our approach across the value chain incorporates sustainable business practices. We care for people, the environment and society, and we do it with full respect for each other’s diverse perspectives and experiences.

We work tirelessly to advance brain health because:

• Brain health conditions impacts almost 3 billion people worldwide.¹
• More than 70% of people living with brain disease experience discrimination.²
• People living with brain disease live between 10-20 years less than healthy individuals.³
• The World Health Organization estimates that the global economy loses about 1 trillion USD a year in productivity due to depression and anxiety alone.⁴
  

Our commitment is to empower patients to give them the tools and resources they need to understand their disease and its unfolding.

Our commitment is to continuously challenge status quo and push our science further to make real differences for patients.

Our commitment is to families to bring evidence-based data, visibility and support to their work in managing a chronic disease.

Our commitment is to communities to end the stigma, fear, and silence that surrounds brain diseases.

Our commitment is to society, to increase access to medicines for the most vulnerable, to act responsibly towards the environment and to behave with respect and integrity in everything we do. 

Fostered by a mindset of “drug hunger”, Lundbeck invests 415M EUR⁶ (close to 20% of our revenue) in brain research annually, we partner with leading research experts and centers and we invest in medical education. 

We seek to empower the brain health advocacy community, we co-create and publish evidence that fights stigma, and we advocate for systemic change to improve the lives of people with brain health conditions.

We ensure that we listen and integrate patient insights throughout Lundbeck’s value-chain, we provide patient education programs, as well as innovative treatments alongside support programs. 

To leverage the support of families, loved ones and carers, we work with caregivers and advocacy groups to support evidence generation and awareness campaigns on the value they bring to disease management.

Research and development of medical treatments is our biggest contribution to society. Our aspiration is to enhance access to brain health for the most vulnerable. We aim to accelerate our efforts through strategic partnerships and collaboration with leading experts.

Science and innovation enable us to foster ground-breaking discoveries within neuroscience. But it also plays a pivotal role in helping us, as a company, prioritize climate action. We are leaders in climate action, and we measure everything we do with the most ambitious reduction targets set by science. Throughout our value chain, we continue to reduce our carbon footprint, becoming more circular and increasing recycling.

Trust is essential. To us, and to our industry. And as a business partner, we promote integrity in the pharmaceutical industry. We take prudent actions to remain responsible. 

At Lundbeck, our most important contribution to society is easing the global burden of the millions of people living with brain diseases. And we are one of the few companies in the world that focus exclusively on this unmet need. For more than 70 years, we’ve been pushing the boundaries of neuroscience. With brain health conditions impacting close the half of the world’s population⁷, it’s more important than ever that we focus and accelerate our efforts. We have demonstrated staying power, specialist knowledge, and a comprehensive approach
to developing treatments.

We are dedicated to help improve the quality of life for people affected by brain disease and ever mindful of this purpose Lundbeck perseveres.